MedPath

重庆胜凯制药有限公司

Ownership
-
Established
2009-08-28
Employees
-
Market Cap
-
Website
https://www.huapontshengchem.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

NMPA:34

Drug Approvals

Levocetirizine Dihydrochloride Oral Solution

Product Name
盐酸左西替利嗪口服溶液
Approval Number
国药准字H20253352
Approval Date
Feb 8, 2025
NMPA

Levocetirizine Dihydrochloride Oral Solution

Product Name
盐酸左西替利嗪口服溶液
Approval Number
国药准字H20253351
Approval Date
Feb 8, 2025
NMPA

Acrivastine

Product Name
阿伐斯汀
Approval Number
国药准字H20080612
Approval Date
Jul 26, 2024
NMPA

Methylprednisolone Hemisuccinate

Product Name
琥珀酸甲泼尼龙
Approval Number
国药准字H20143026
Approval Date
Jul 3, 2024
NMPA

Desonide Cream

Product Name
地奈德乳膏
Approval Number
国药准字H20243244
Approval Date
Feb 23, 2024
NMPA

Isotretinoin Soft Capsules

Product Name
异维A酸软胶囊
Approval Number
国药准字H20234744
Approval Date
Dec 29, 2023
NMPA

Acitretin Capsules

Product Name
阿维A胶囊
Approval Number
国药准字H20233806
Approval Date
Jun 27, 2023
NMPA

Calcium Levofolinate

Product Name
左亚叶酸钙
Approval Number
国药准字H20130016
Approval Date
Mar 3, 2023
NMPA

Methoxsalen

Product Name
甲氧沙林
Approval Number
国药准字H20083067
Approval Date
Mar 3, 2023
NMPA

Dapsone

Product Name
氨苯砜
Approval Number
国药准字H20133074
Approval Date
Mar 3, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.